BRKR
Bruker Corporation
Price Chart
Latest Quote
$57.23
+2.50 (+4.57%)
Current Price
| Previous Close | $54.73 |
| Open | $55.36 |
| Day High | $57.45 |
| Day Low | $54.27 |
| Volume | 1,979,262 |
Stock Information
| Quarterly Dividend / Yield | $0.20 / 0.36% |
| Shares Outstanding | 152.23M |
| Quarterly Dividend Yield | 0.36% |
| Quarterly Dividend | $0.20 |
| Total Debt | $1.70B |
| Cash Equivalents | $133.40M |
| Revenue | $3.46B |
| Net Income | $-36.40M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $8.71B |
| EPS (TTM) | $-0.24 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.12B |
| Sales | $3.46B |
| Income | $-36.40M |
| Book/sh | $16.09 |
| Cash/sh | $0.88 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 0.65 |
| Current Ratio | 1.55 |
| Debt/Eq | 68.12 |
| EPS Growth TTM | -17.20% |
Returns & Margins
| ROA | 2.70% |
| ROE | -0.43% |
| Gross Margin | 47.62% |
| Operating Margin | 6.18% |
| Profit Margin | -0.34% |
Ownership
| Insider Ownership | 26.95% |
| Institutional Ownership | 92.77% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 23.49 |
| PEG | 1.52 |
| P/S | 2.52 |
| P/B | 3.56 |
Analyst Data
| Recommendation | buy |
| Target Price | $53.25 |
Technical Indicators
| SMA20 | $54.83 |
| SMA50 | $45.95 |
| SMA200 | $41.79 |
| RSI | 46.64 |
| ATR | 3.0933 |
| Shares Float | 103.57M |
| Short Float | 17.41% |
| Short Ratio | 5.07 |
| Volatility | 1.30 |
| Rel Volume | 0.67 |
Performance History
| Week | +3.72% |
| Month | +34.37% |
| Quarter | +70.43% |
| 6 Months | +27.48% |
| YTD | +19.14% |
| Year | +52.75% |
| 3 Years | -24.70% |
| 5 Years | -20.87% |
| 10 Years | +144.10% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $57.23 | 1,979,262 |
| 2026-06-17 | $54.73 | 1,774,900 |
| 2026-06-16 | $55.80 | 1,764,100 |
| 2026-06-15 | $56.63 | 3,499,100 |
| 2026-06-12 | $54.23 | 2,371,600 |
| 2026-06-11 | $55.18 | 2,255,800 |
| 2026-06-10 | $54.92 | 1,376,200 |
| 2026-06-09 | $57.24 | 2,248,400 |
| 2026-06-08 | $56.26 | 2,732,800 |
| 2026-06-05 | $56.39 | 3,588,000 |
| 2026-06-04 | $59.97 | 5,790,000 |
| 2026-06-03 | $62.70 | 4,417,100 |
| 2026-06-02 | $57.31 | 2,537,000 |
| 2026-06-01 | $58.44 | 4,136,900 |
| 2026-05-29 | $58.89 | 6,051,600 |
| 2026-05-28 | $54.39 | 4,792,900 |
| 2026-05-27 | $48.62 | 2,503,900 |
| 2026-05-26 | $46.92 | 2,054,700 |
| 2026-05-22 | $45.69 | 1,506,400 |
| 2026-05-21 | $44.98 | 1,624,700 |
| 2026-05-20 | $44.26 | 1,865,800 |
| 2026-05-19 | $42.59 | 2,255,200 |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
đ° Latest News
No news articles available at the moment. Check back later for updates on BRKR.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,858,800,000 | $1,716,900,000 | $1,451,200,000 | $1,225,000,000 |
| Cost Of Revenue | $1,858,800,000 | $1,716,900,000 | $1,451,200,000 | $1,225,000,000 |
| Total Revenue | $3,436,500,000 | $3,366,400,000 | $2,964,500,000 | $2,530,700,000 |
| Operating Revenue | $3,436,500,000 | $3,366,400,000 | $2,964,500,000 | $2,530,700,000 |
| Expenses | ||||
| Interest Expense | $60,300,000 | $47,900,000 | $16,400,000 | $16,100,000 |
| Total Expenses | $3,200,500,000 | $2,987,200,000 | $2,475,400,000 | $2,068,300,000 |
| Other Income Expense | $-167,300,000 | $-133,700,000 | $60,300,000 | $-36,500,000 |
| Other Non Operating Income Expenses | $-13,100,000 | $-9,700,000 | $-11,000,000 | $-7,200,000 |
| Net Non Operating Interest Income Expense | $-46,700,000 | $-38,600,000 | $-5,200,000 | $-12,000,000 |
| Total Other Finance Cost | $1,200,000 | - | $-3,700,000 | $-1,300,000 |
| Interest Expense Non Operating | $60,300,000 | $47,900,000 | $16,400,000 | $16,100,000 |
| Operating Expense | $1,341,700,000 | $1,270,300,000 | $1,024,200,000 | $843,300,000 |
| General And Administrative Expense | $946,500,000 | $893,800,000 | $729,400,000 | $607,400,000 |
| Other Operating Expenses | - | - | $10,300,000 | $3,800,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,600,000 | $113,100,000 | $427,200,000 | $296,600,000 |
| Net Interest Income | $-46,700,000 | $-38,600,000 | $-5,200,000 | $-12,000,000 |
| Interest Income | $14,800,000 | $9,300,000 | $7,500,000 | $2,800,000 |
| Normalized Income | $113,218,000 | $211,060,000 | $371,300,800 | $317,666,700 |
| Net Income From Continuing And Discontinued Operation | $-8,600,000 | $113,100,000 | $427,200,000 | $296,600,000 |
| Total Operating Income As Reported | $68,200,000 | $253,100,000 | $436,900,000 | $432,700,000 |
| Net Income Common Stockholders | $-22,500,000 | $113,100,000 | $427,200,000 | $296,600,000 |
| Net Income | $-8,600,000 | $113,100,000 | $427,200,000 | $296,600,000 |
| Net Income Including Noncontrolling Interests | $-8,300,000 | $113,800,000 | $428,500,000 | $298,500,000 |
| Net Income Continuous Operations | $-8,300,000 | $113,800,000 | $428,500,000 | $298,500,000 |
| Earnings From Equity Interest Net Of Tax | $-1,000,000 | $-1,700,000 | $2,000,000 | $1,000,000 |
| Pretax Income | $22,000,000 | $206,900,000 | $544,200,000 | $413,900,000 |
| Special Income Charges | $-171,700,000 | $-147,700,000 | $84,600,000 | $-23,500,000 |
| Interest Income Non Operating | $14,800,000 | $9,300,000 | $7,500,000 | $2,800,000 |
| Operating Income | $236,000,000 | $379,200,000 | $489,100,000 | $462,400,000 |
| Gross Profit | $1,577,700,000 | $1,649,500,000 | $1,513,300,000 | $1,305,700,000 |
| Per Share | ||||
| Diluted EPS | $-0.15 | $0.76 | $2.90 | $1.99 |
| Basic EPS | $-0.15 | $0.76 | $2.92 | $2.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $-32,382,000 | $-26,040,000 | $15,400,800 | $-8,233,300 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $456,800,000 | $562,600,000 | $604,200,000 | $548,000,000 |
| Total Unusual Items | $-154,200,000 | $-124,000,000 | $71,300,000 | $-29,300,000 |
| Reconciled Depreciation | $220,300,000 | $183,800,000 | $114,900,000 | $88,700,000 |
| EBITDA (Bullshit earnings) | $302,600,000 | $438,600,000 | $675,500,000 | $518,700,000 |
| EBIT | $82,300,000 | $254,800,000 | $560,600,000 | $430,000,000 |
| Diluted Average Shares | $151,800,000 | $149,500,000 | $147,200,000 | $149,400,000 |
| Basic Average Shares | $151,800,000 | $149,000,000 | $146,400,000 | $148,600,000 |
| Diluted NI Availto Com Stockholders | $-22,500,000 | $113,100,000 | $427,200,000 | $296,600,000 |
| Preferred Stock Dividends | $13,900,000 | - | - | - |
| Minority Interests | $-300,000 | $-700,000 | $-1,300,000 | $-1,900,000 |
| Tax Provision | $29,300,000 | $91,400,000 | $117,700,000 | $116,400,000 |
| Other Special Charges | $35,300,000 | $44,900,000 | - | - |
| Write Off | $20,000,000 | $24,600,000 | $18,200,000 | $0 |
| Impairment Of Capital Assets | $111,300,000 | $2,200,000 | $5,700,000 | $300,000 |
| Restructuring And Mergern Acquisition | $5,100,000 | $76,000,000 | $-108,500,000 | $23,200,000 |
| Gain On Sale Of Security | $17,500,000 | $23,700,000 | $-13,300,000 | $-5,800,000 |
| Research And Development | $395,200,000 | $376,500,000 | $294,800,000 | $235,900,000 |
| Selling General And Administration | $946,500,000 | $893,800,000 | $729,400,000 | $607,400,000 |
| Other Gand A | $946,500,000 | $893,800,000 | $729,400,000 | $607,400,000 |
| Salaries And Wages | - | - | $100,000 | $1,000,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $9,200,000 | $-638,600,000 | $464,100,000 | $385,300,000 |
| Total Assets | $6,241,400,000 | $5,806,700,000 | $4,249,900,000 | $3,611,800,000 |
| Total Non Current Assets | $4,028,900,000 | $3,753,500,000 | $2,085,700,000 | $1,498,600,000 |
| Other Non Current Assets | $249,300,000 | $232,700,000 | $184,000,000 | $155,100,000 |
| Non Current Deferred Assets | $421,700,000 | $286,200,000 | $297,200,000 | $76,800,000 |
| Non Current Deferred Taxes Assets | $421,700,000 | $286,200,000 | $297,200,000 | $76,800,000 |
| Goodwill And Other Intangible Assets | $2,447,300,000 | $2,419,800,000 | $913,100,000 | $728,500,000 |
| Other Intangible Assets | $899,600,000 | $912,500,000 | $330,500,000 | $270,900,000 |
| Current Assets | $2,212,500,000 | $2,053,200,000 | $2,164,200,000 | $2,113,200,000 |
| Other Current Assets | $24,100,000 | $28,900,000 | $18,300,000 | $12,800,000 |
| Hedging Assets Current | $0 | $10,700,000 | $12,000,000 | $14,800,000 |
| Prepaid Assets | $59,000,000 | $61,200,000 | $55,500,000 | $43,300,000 |
| Inventory | $1,094,600,000 | $1,067,800,000 | $968,300,000 | $800,100,000 |
| Receivables | $736,000,000 | $701,200,000 | $621,800,000 | $595,300,000 |
| Other Receivables | $116,900,000 | $101,200,000 | $83,900,000 | $60,800,000 |
| Taxes Receivable | $74,200,000 | $34,500,000 | $45,900,000 | $61,800,000 |
| Accounts Receivable | $544,900,000 | $565,500,000 | $492,000,000 | $472,700,000 |
| Cash Cash Equivalents And Short Term Investments | $298,800,000 | $183,400,000 | $488,300,000 | $645,500,000 |
| Cash And Cash Equivalents | $298,800,000 | $183,400,000 | $488,300,000 | $645,500,000 |
| Allowance For Doubtful Accounts Receivable | - | $-6,500,000 | $-4,600,000 | $-5,300,000 |
| Gross Accounts Receivable | - | $572,000,000 | $496,600,000 | $478,000,000 |
| Assets Held For Sale Current | - | - | $0 | $1,400,000 |
| Debt | ||||
| Net Debt | $1,570,300,000 | $1,910,900,000 | $793,200,000 | $573,700,000 |
| Total Debt | $2,042,900,000 | $2,245,300,000 | $1,379,600,000 | $1,270,400,000 |
| Long Term Debt And Capital Lease Obligation | $1,991,100,000 | $2,180,700,000 | $1,235,100,000 | $1,235,300,000 |
| Long Term Debt | $1,852,500,000 | $2,061,800,000 | $1,160,300,000 | $1,200,500,000 |
| Current Debt And Capital Lease Obligation | $51,800,000 | $64,600,000 | $144,500,000 | $35,100,000 |
| Current Debt | $16,600,000 | $32,500,000 | $121,200,000 | $18,700,000 |
| Other Current Borrowings | $16,600,000 | $32,500,000 | $121,200,000 | $18,700,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,731,100,000 | $3,991,500,000 | $2,836,600,000 | $2,480,000,000 |
| Total Non Current Liabilities Net Minority Interest | $2,451,900,000 | $2,710,200,000 | $1,634,500,000 | $1,565,700,000 |
| Other Non Current Liabilities | $239,200,000 | $311,000,000 | $240,200,000 | $120,800,000 |
| Non Current Deferred Liabilities | $221,600,000 | $218,500,000 | $159,200,000 | $163,900,000 |
| Non Current Deferred Taxes Liabilities | $112,500,000 | $118,500,000 | $67,700,000 | $62,300,000 |
| Current Liabilities | $1,279,200,000 | $1,281,300,000 | $1,202,100,000 | $914,300,000 |
| Other Current Liabilities | $165,100,000 | $33,400,000 | $51,800,000 | $23,800,000 |
| Current Deferred Liabilities | $441,300,000 | $438,200,000 | $400,000,000 | $370,200,000 |
| Payables And Accrued Expenses | $441,300,000 | $557,300,000 | $439,300,000 | $349,100,000 |
| Interest Payable | $7,100,000 | $10,000,000 | - | - |
| Payables | $324,900,000 | $376,600,000 | $360,100,000 | $282,400,000 |
| Dividends Payable | $11,500,000 | $0 | - | - |
| Total Tax Payable | $97,500,000 | $142,500,000 | $157,400,000 | $104,000,000 |
| Income Tax Payable | $76,200,000 | $119,600,000 | $138,700,000 | $85,500,000 |
| Accounts Payable | $215,900,000 | $234,100,000 | $202,700,000 | $178,400,000 |
| Equity | ||||
| Common Stock Equity | $2,456,500,000 | $1,781,200,000 | $1,377,200,000 | $1,113,800,000 |
| Total Equity Gross Minority Interest | $2,510,300,000 | $1,815,200,000 | $1,413,300,000 | $1,131,800,000 |
| Gains Losses Not Affecting Retained Earnings | $-79,500,000 | $-103,500,000 | $6,000,000 | $14,800,000 |
| Other Equity Adjustments | $-79,500,000 | $-103,500,000 | $6,000,000 | $14,800,000 |
| Retained Earnings | $2,361,800,000 | $2,406,700,000 | $2,323,800,000 | $1,926,000,000 |
| Preferred Securities Outside Stock Equity | - | - | - | $6,100,000 |
| Other | ||||
| Treasury Shares Number | $30,904,588 | $30,778,879 | $30,778,879 | $28,366,442 |
| Ordinary Shares Number | $152,143,041 | $151,677,952 | $145,164,826 | $147,023,144 |
| Share Issued | $183,047,629 | $182,456,831 | $175,943,705 | $175,389,586 |
| Tangible Book Value | $9,200,000 | $-638,600,000 | $464,100,000 | $385,300,000 |
| Invested Capital | $4,325,600,000 | $3,875,500,000 | $2,658,700,000 | $2,333,000,000 |
| Working Capital | $933,300,000 | $771,900,000 | $962,100,000 | $1,198,900,000 |
| Capital Lease Obligations | $173,800,000 | $151,000,000 | $98,100,000 | $51,200,000 |
| Total Capitalization | $4,309,000,000 | $3,843,000,000 | $2,537,500,000 | $2,314,300,000 |
| Minority Interest | $53,800,000 | $34,000,000 | $36,100,000 | $18,000,000 |
| Treasury Stock | $1,242,200,000 | $1,237,200,000 | $1,237,200,000 | $1,085,000,000 |
| Additional Paid In Capital | $1,414,600,000 | $713,400,000 | $282,900,000 | $256,300,000 |
| Capital Stock | $1,800,000 | $1,800,000 | $1,700,000 | $1,700,000 |
| Common Stock | $1,800,000 | $1,800,000 | $1,700,000 | $1,700,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $109,100,000 | $100,000,000 | $91,500,000 | $101,600,000 |
| Long Term Capital Lease Obligation | $138,600,000 | $118,900,000 | $74,800,000 | $34,800,000 |
| Current Deferred Revenue | $441,300,000 | $438,200,000 | $400,000,000 | $370,200,000 |
| Current Capital Lease Obligation | $35,200,000 | $32,100,000 | $23,300,000 | $16,400,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $179,700,000 | $187,800,000 | $166,500,000 | $136,100,000 |
| Current Accrued Expenses | $116,400,000 | $180,700,000 | $79,200,000 | $66,700,000 |
| Goodwill | $1,547,700,000 | $1,507,300,000 | $582,600,000 | $457,600,000 |
| Net PPE | $910,600,000 | $814,800,000 | $691,400,000 | $538,200,000 |
| Accumulated Depreciation | $-692,000,000 | $-559,000,000 | $-524,200,000 | $-446,700,000 |
| Gross PPE | $1,602,600,000 | $1,373,800,000 | $1,215,600,000 | $984,900,000 |
| Other Properties | $165,800,000 | $145,500,000 | $91,700,000 | $51,200,000 |
| Machinery Furniture Equipment | $749,200,000 | $640,100,000 | $586,900,000 | $462,600,000 |
| Buildings And Improvements | $612,000,000 | $540,700,000 | $498,100,000 | $434,500,000 |
| Land And Improvements | $75,600,000 | $47,500,000 | $38,900,000 | $36,600,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Inventories | $115,900,000 | $101,700,000 | $98,300,000 | $92,300,000 |
| Finished Goods | $243,100,000 | $228,500,000 | $183,900,000 | $128,200,000 |
| Work In Process | $343,600,000 | $348,900,000 | $314,900,000 | $278,700,000 |
| Raw Materials | $392,000,000 | $388,700,000 | $371,200,000 | $300,900,000 |
| Employee Benefits | - | - | $76,600,000 | $45,700,000 |
| Non Current Pension And Other Postretirement Benefit Plans | - | - | $76,600,000 | $45,700,000 |
| Other Short Term Investments | - | - | - | $0 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $13,900,000 | $136,000,000 | $243,200,000 | $145,200,000 |
| Operating Activities | ||||
| Operating Cash Flow | $134,100,000 | $251,300,000 | $350,100,000 | $274,400,000 |
| Cash Flow From Continuing Operating Activities | $134,100,000 | $251,300,000 | $350,100,000 | $274,300,000 |
| Operating Gains Losses | $-56,000,000 | $-28,100,000 | $18,500,000 | $-10,100,000 |
| Investing Activities | ||||
| Capital Expenditure | $-120,200,000 | $-115,300,000 | $-106,900,000 | $-129,200,000 |
| Investing Cash Flow | $-196,500,000 | $-1,757,300,000 | $-326,000,000 | $-251,600,000 |
| Cash Flow From Continuing Investing Activities | $-196,500,000 | $-1,757,300,000 | $-326,000,000 | $-251,600,000 |
| Net Other Investing Changes | $4,800,000 | $5,900,000 | $32,300,000 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-10,000,000 | $0 | $-152,300,000 | $-263,100,000 |
| Issuance Of Capital Stock | $677,600,000 | $409,000,000 | $9,500,000 | $0 |
| Financing Cash Flow | $135,100,000 | $1,229,800,000 | $-193,400,000 | $-415,300,000 |
| Cash Flow From Continuing Financing Activities | $135,100,000 | $1,229,800,000 | $-193,400,000 | $-415,300,000 |
| Net Other Financing Charges | $-8,300,000 | $-24,900,000 | $300,000 | $-14,500,000 |
| Cash Dividends Paid | $-32,900,000 | $-30,200,000 | $-29,400,000 | $-29,800,000 |
| Preferred Stock Dividend Paid | $-10,100,000 | $0 | $0 | - |
| Common Stock Dividend Paid | $-22,800,000 | $-30,200,000 | $-29,400,000 | $-29,800,000 |
| Net Preferred Stock Issuance | $669,700,000 | $0 | $0 | - |
| Preferred Stock Issuance | $669,700,000 | $0 | $0 | - |
| Net Common Stock Issuance | $-2,100,000 | $409,000,000 | $-142,800,000 | $-263,100,000 |
| Common Stock Issuance | $7,900,000 | $409,000,000 | $9,500,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-1,245,300,000 | $-1,348,100,000 | $-23,500,000 | $-111,000,000 |
| Issuance Of Debt | $754,000,000 | $2,224,000,000 | $2,000,000 | $300,000 |
| Interest Paid Supplemental Data | $71,000,000 | $54,600,000 | $33,700,000 | $24,300,000 |
| Income Tax Paid Supplemental Data | $222,500,000 | $153,900,000 | $96,600,000 | $147,400,000 |
| End Cash Position | $303,100,000 | $186,700,000 | $491,600,000 | $648,700,000 |
| Beginning Cash Position | $186,700,000 | $491,600,000 | $648,700,000 | $1,071,700,000 |
| Effect Of Exchange Rate Changes | $43,700,000 | $-28,700,000 | $12,200,000 | $-30,500,000 |
| Changes In Cash | $72,700,000 | $-276,200,000 | $-169,300,000 | $-392,500,000 |
| Common Stock Payments | $-10,000,000 | $0 | $-152,300,000 | $-263,100,000 |
| Net Issuance Payments Of Debt | $-491,300,000 | $875,900,000 | $-21,500,000 | $-110,700,000 |
| Net Long Term Debt Issuance | $-491,300,000 | $875,900,000 | $-21,500,000 | $-110,700,000 |
| Long Term Debt Payments | $-1,245,300,000 | $-1,348,100,000 | $-23,500,000 | $-111,000,000 |
| Long Term Debt Issuance | $754,000,000 | $2,224,000,000 | $2,000,000 | $300,000 |
| Net Investment Purchase And Sale | $-7,200,000 | $-48,300,000 | $-24,800,000 | $46,000,000 |
| Purchase Of Investment | $-7,200,000 | $-48,300,000 | $-24,800,000 | $-60,200,000 |
| Net Business Purchase And Sale | $-73,900,000 | $-1,599,600,000 | $-226,600,000 | $-182,300,000 |
| Purchase Of Business | $-73,900,000 | $-1,599,600,000 | $-226,600,000 | $-182,300,000 |
| Net Intangibles Purchase And Sale | $-29,400,000 | $0 | $0 | - |
| Purchase Of Intangibles | $-29,400,000 | $0 | $0 | - |
| Net PPE Purchase And Sale | $-90,800,000 | $-115,300,000 | $-106,900,000 | $-115,300,000 |
| Purchase Of PPE | $-90,800,000 | $-115,300,000 | $-106,900,000 | $-129,200,000 |
| Change In Working Capital | $-144,800,000 | $-118,800,000 | $-87,800,000 | $-144,100,000 |
| Change In Other Working Capital | $-52,900,000 | $-29,300,000 | $-28,700,000 | $35,200,000 |
| Change In Payables And Accrued Expense | $-158,200,000 | $20,900,000 | $66,800,000 | $26,500,000 |
| Change In Accrued Expense | $-26,700,000 | $15,400,000 | $21,900,000 | - |
| Change In Payable | $-131,500,000 | $5,500,000 | $44,900,000 | $26,500,000 |
| Change In Account Payable | $-37,500,000 | $20,800,000 | $1,200,000 | $33,300,000 |
| Change In Tax Payable | $-94,000,000 | $-15,300,000 | $43,700,000 | $-6,800,000 |
| Change In Income Tax Payable | $-94,000,000 | $-15,300,000 | $43,700,000 | $-6,800,000 |
| Change In Inventory | $12,100,000 | $-69,800,000 | $-125,000,000 | $-137,900,000 |
| Change In Receivables | $54,200,000 | $-40,600,000 | $-900,000 | $-67,900,000 |
| Changes In Account Receivables | $54,200,000 | $-40,600,000 | $-900,000 | $-67,900,000 |
| Other Non Cash Items | $-21,100,000 | $50,400,000 | $-172,100,000 | $26,900,000 |
| Stock Based Compensation | $20,200,000 | $25,300,000 | $30,900,000 | $27,700,000 |
| Asset Impairment Charge | $228,300,000 | $88,700,000 | $41,600,000 | $1,600,000 |
| Deferred Tax | $-104,500,000 | $-63,800,000 | $-24,400,000 | $-14,800,000 |
| Deferred Income Tax | $-104,500,000 | $-63,800,000 | $-24,400,000 | $-14,800,000 |
| Depreciation Amortization Depletion | $220,300,000 | $183,800,000 | $114,900,000 | $88,700,000 |
| Depreciation And Amortization | $220,300,000 | $183,800,000 | $114,900,000 | $88,700,000 |
| Amortization Cash Flow | $121,200,000 | $99,100,000 | $47,100,000 | $37,100,000 |
| Amortization Of Intangibles | $121,200,000 | $99,100,000 | $47,100,000 | $37,100,000 |
| Depreciation | $99,100,000 | $84,700,000 | $67,800,000 | $51,600,000 |
| Net Foreign Currency Exchange Gain Loss | $-56,000,000 | $-28,100,000 | $18,500,000 | - |
| Net Income From Continuing Operations | $-8,300,000 | $113,800,000 | $428,500,000 | $298,500,000 |
| Proceeds From Stock Option Exercised | - | $6,000,000 | $9,500,000 | $2,800,000 |
| Sale Of Investment | - | $4,800,000 | $21,200,000 | $106,200,000 |
| Sale Of PPE | - | $1,100,000 | $11,100,000 | $13,900,000 |
| Gain Loss On Sale Of PPE | - | $4,600,000 | $-8,500,000 | $-10,100,000 |
| Gain Loss On Investment Securities | - | - | $-6,800,000 | - |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-06-17